ICU Medical, Inc. Aktie News

SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call.

ICU Medical, Inc. (ICUI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P.

ICU Medical has emerged from a painful post-Smiths Medical integration process, shifting focus from remediation to growth and margin expansion. Essentially divesting the low-margin IV solutions business to Otsuka and launching new products can drive gross margin improvement toward 43%-45%. ICUI should achieve sustained EBITDA margins above 20% and double-digit FCF growth, supporting deleveragin...

SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical's fireside chat will be on Thursday, D...

ICU Medical, Inc. ( ICUI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Deirdre Thomson - ICR Inc. Jayson Bedford - Raymond James & Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Matson - Needham & Company, ...

SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025.

SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.